Lilly raises outlook for third time this year as Zepbound sales soar.

Image: MarketWatch
ad slot · in-content video 16:9
Coverage
Coverage
- The drug continues to dominate the market for prescription weight-loss drugs in the U.S.
Technology news, aggregated

Image: MarketWatch
Coverage